hypericin has been researched along with Sarcoma, Epithelioid in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to investigate the hypothesis that radioiodinated hypericin (131I-Hyp) may inhibit residual tumor recurrence after microwave ablation (MWA) on rat orthotopic liver allograft sarcoma models." | 7.83 | Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy. ( Gao, L; Gao, M; Ma, T; Ni, Y; Shan, X; Shao, H; Xu, K; Yao, N; Zhang, J, 2016) |
| "Hypericin has an excellent necrosis-specific targeting capacity; thus, we explored small-molecular tumor necrosis therapy (SMTNT) for inhibiting tumor growth in rodent tumor models." | 7.81 | Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models. ( Feng, Y; Gao, M; Huang, D; Jiang, C; Jiang, X; Jing, S; Li, Y; Liu, W; Ni, Y; Peng, F; Wang, X; Zhang, D; Zhang, J, 2015) |
| " This study aimed to investigate the hypothesis that radioiodinated hypericin (131I-Hyp) may inhibit residual tumor recurrence after microwave ablation (MWA) on rat orthotopic liver allograft sarcoma models." | 3.83 | Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy. ( Gao, L; Gao, M; Ma, T; Ni, Y; Shan, X; Shao, H; Xu, K; Yao, N; Zhang, J, 2016) |
| "Hypericin has an excellent necrosis-specific targeting capacity; thus, we explored small-molecular tumor necrosis therapy (SMTNT) for inhibiting tumor growth in rodent tumor models." | 3.81 | Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models. ( Feng, Y; Gao, M; Huang, D; Jiang, C; Jiang, X; Jing, S; Li, Y; Liu, W; Ni, Y; Peng, F; Wang, X; Zhang, D; Zhang, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Zhang, D | 1 |
| Feng, Y | 1 |
| Li, Y | 1 |
| Huang, D | 1 |
| Jiang, C | 1 |
| Gao, M | 2 |
| Peng, F | 1 |
| Wang, X | 1 |
| Jing, S | 1 |
| Jiang, X | 1 |
| Ni, Y | 2 |
| Zhang, J | 2 |
| Gao, L | 1 |
| Ma, T | 1 |
| Yao, N | 1 |
| Shan, X | 1 |
| Shao, H | 1 |
| Xu, K | 1 |
2 other studies available for hypericin and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Topics: Animals; Anthracenes; Antineoplastic Agents; Autoradiography; Carcinoma, Hepatocellular; Cell Line, | 2015 |
Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
Topics: Allografts; Animals; Anthracenes; Cell Line, Tumor; Combined Modality Therapy; Hyperthermia, Induced | 2016 |